The immune response of mice to live, heat-killed, or autoclaved Mycobacterium leprae was investigated.
In the search for a leprosy vaccine, a general approach taken by Shepard is the use of Mycobacterium leprae itself (13, 15) . This approach has resulted in establishing the fact that M. leprae has immunoprotective qualities whether it is administered as a viable or as a nonviable vaccine. Immunity is manifested as the restriction or prevention of multiplication of the organisms in an inoculum of 5,000 M. leprae in the footpads of mice.
The purpose of this study was to assess acquired immunity to M. leprae via adoptive transfer studies. Lymphocyte transformation and delayed hypersensitivity, indices of cellmediated immunity, were used to measure transfer of sensitivity of lymphocytes sensitized to various M. leprae preparations, either viable, killed by heat, or autoclaved. Transfer of protective immunity, specific as well as nonspecific, was also assessed.
MATERIALS AND METHODS
Experimental animals. Six-to eight-week-old female BALB/c mice purchased from Harlan Sprague-Dawley, Inc., Indianapolis, Ind., were used throughout the studies. Immunization rads from a 137Cs source. All lymphoid cell recipients were injected intravenously with 108 cells per animal.
M. leprae infection. The spleen cell recipients reserved for infection were injected via the left hind footpad with 5 x 103 M. leprae in 0.02 ml of phosphate-buffered saline. Bacterial assays were performed at 120 days and are presented according to the method described by Shepard (14) . When these studies were repeated later, duplicate footpads were sent to A. M. Dhople, Florida Institute of Technology, Melbourne, for bacterial assay to ensure the validity of our observations. Lymphocyte transformation. Five mice in each group were sacrificed at predetermined intervals, and their spleens were processed to obtain a final cell pellet, which was resuspended at a concentration of 106 cells per ml of RPMI 1640 tissue culture medium containing 100 U of penicillin and 100 ,ug of streptomycin per ml of medium supplemented with 0.3% glutamine and 10% heat-inactivated fetal calf serum (Difco Laboratories, Detroit, Mich.). All cultures were incubated in triplicate at 37°C in a 5% CO2 in air mixture after the addition of sonicated M. leprae cell extract (25 ,ug of protein per ml) and phytohemagglutinin (10 RI/ml). All tubes were cultured for 96 h after pulse-labeling with 0.1 ,uCi of tritiated thymidine (specific activity, 1.9 Ci/mmol; Schwarzmann) in 0.1 ml of Hanks balanced salt solution approximately 20 h before culture termination. Cells were then washed twice in ice-cold 0.15 M NaCl and precipitated twice in cold 5% (wt/ vol) trichloroacetic acid for 10 min. The final trichloroacetic acid-insoluble precipitates were dried overnight at room temperature and dissolved in 0.4 ml of Hyamine hydroxide. The dissolved material was transferred with 2 Fig. 1 show the swelling at 48 h since there was no significant increase observed thereafter. The reaction was stronger at week 3 after adoptive transfer in the test groups (Fig. 2) .
Lymphocyte transformation. Figure 3 gives the data on lymphocyte transformation studies. (10) (11) (12) . The data in this study are essentially in agreement with the latter observations and reveal that effective immunity can be established either with or without prior irradiation of the recipients, although the former may facilitate a better expression of protection than the latter, as can be seen from the number of bacillary-negative animals in the irradiated group. Negative status as expressed here denotes bacillary counts from zero to 104. Our results on the immunogenicity of M. leprae are in agreement with those of Shepard et al. (15) , who reported findings in mice that were immunized 28 days before the challenge infection. However, there are basic differences between the two approaches. In the Shepard system, the additive effects of adjuvant activity in M. Ieprae and the ability of these organisms to persist in the tissues, even when dead, appear to serve as a constant immunological stimulus in the vaccinated animals (15). In our system, however, such continuous antigenic stimulus is either reduced or perhaps even absent in the adoptively challenged recipients, thus demonstrating the immune capabilities of the sensitized lymphocytes. The possibility that some soluble antigen could have been transfused with the sensitized splenocytes does exist. However, the antigen that is released by both viable and nonviable organisms into the host system could be limited considering the short period of time between immunization and transfusion. 
